Susquehanna International Group, LLP Foghorn Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$2.82 - $7.94 $13,392 - $37,707	4,749 Added 41.91%	16,080 $107,000
Q4 2023 Feb 14, 2024	SELL	$2.94 - $6.76 $58,820 - $135,247	-20,007 Reduced 63.84%	11,331 $73,000
Q3 2023 Nov 14, 2023	SELL	$5.0 - $9.87 $118,420 - $233,761	-23,684 Reduced 43.04%	31,338 $156,000
Q2 2023 Aug 11, 2023	BUY	$5.37 - $8.84 $227,500 - $374,506	42,365 Added 334.72%	55,022 $387,000
Q1 2023 May 16, 2023	BUY	$4.66 - $8.99 $58,981 - $113,786	12,657 New	12,657 $78,000
Q1 2021 May 17, 2021	SELL	$11.8 - $23.11 $329,680 - $645,670	-27,939 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.12 - $25.88 $422,437 - $723,061	27,939 New	27,939 $566,000

32.7M

1.8K

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $336M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.